Xiaohong He

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Clinical Cancer Research · 2021 · 274 citations · Full text

Life Sciences, Immunology, Oncology +17

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Cell Research · 2022 · 190 citations · Full text

Medicine, Hematology, Immunology +16

sirt1-null mice develop an autoimmune-like condition

Jedon Sequeira, Gino Boily, Stephanie Bazinet et al. · Experimental Cell Research · 2008 · 133 citations

Life Sciences, Genetics, Immunology +10

Exome sequencing reveals genetic differentiation due to high-altitude adaptation in the Tibetan cashmere goat (Capra hircus)

Shen Song, Na Yao, Min Yang et al. · BMC Genomics · 2016 · 114 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome

Annabelle Z. Caron, Xiaohong He, Walid Mottawea et al. · The FASEB Journal · 2013 · 83 citations

Life Sciences, Biochemistry, Molecular Genetics +17